Posts Tagged 'Pradaxa warning'

Anticlotting drug Pradaxa causing deaths

Pradaxa has been linked to more than 500 deaths in the United States. A chorus of complaints has risen from doctors, victims’ families and others in the medical community, who worry that the approval process was not sufficiently rigorous because it allowed a potentially dangerous drug to be sold without an option for reversing its effects.

Read more about the deaths linked to Pradaxa…

Study warns of excess bleeding risk with Pradaxa

A new study published in the New England Journal of Medicine warns that the lack of an effective treatment for severe bleeding caused by Pradaxa may put the lives of patients taking the drug at risk. The study by researchers at the Haematology Society of Australia and New Zealand examined the cases of dozens of patients who experienced excess bleeding after taking Pradaxa.

Click here to read more…

Study warns of excess bleeding risk with Pradaxa

A new study published in the New England Journal of Medicine warns that the lack of an effective treatment for severe bleeding caused by Pradaxa may put the lives of patients at risk. The study by researchers at the Haematology Society of Australia and New Zealand examined the cases of dozens of patients who experienced excess bleeding after taking Pradaxa.

Click here to read more…

Minor falls more risky with new blood thinner, Utah docs warn

A study published in the Journal of Neurosurgery adds to a growing chorus of concern about Pradaxa. Approved in October 2010, Pradaxa has been shown in clinical trials to do a better job than other blood thinners at reducing the risk of stroke in some patients. But once bleeding starts, it’s largely irreversible, because there’s “no known agent” to counteract Pradaxa’s effects.

Click here to read more…

Death magnifies Pradaxa hemorrhage concerns

The death of an elderly man from a massive brain hemorrhage after a routine fall suggests that bleeding complications from Boehringer Ingelheim’s Pradaxa blood clot preventer are largely irreversible, according to the Journal of Neurosurgery. The recently approved drug is the first in a new class of oral medicines called direct thrombin inhibitors, approved to prevent strokes among patients with a dangerous irregular heartbeat called atrial fibrillation that mostly affects the elderly.

Click here to read more…

Blood-thinning drug linked to heart attack risk

People who take the recently approved blood-thinning medication dabigatran could have a slightly increased risk of heart attack compared with people who use the old standby drug warfarin, new research suggests. Sold under the brand name Pradaxa, dabigatran has been taken by an estimated 500,000 people to prevent blood clots that could cause stroke.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 428 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.


Follow

Get every new post delivered to your Inbox.

Join 428 other followers